Kazeev Valerij Ivanovich,Казеев Валерий Иванович,Kazeeva Natalya Vladimirovna,Казеева Наталья Владимировна,Kazeev Maksim Valerevich,Казеев Максим Валерьевич
申请号：
RU2016139453
公开号：
RU0002650043C1
申请日:
2016.10.07
申请国别(地区):
RU
年份:
2018
代理人:
摘要：
FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to oncology, and can be used to guide patients after the primary detection of skin cancer in them. For this purpose, clinical examination is carried out with carrying out of examinations in the volume necessary for the timely diagnosis of new malignant tumors, including other localization. When a patient is diagnosed with skin cancer, clinical examination is performed within the first 10 years. At the same time, during the first five years, patients undergo an oncological examination twice a year, chest x-ray 2 times a year, fibrogatroduodenoscopy once a year, fibrocolonoscopy once a year, ultrasound examination of the abdominal cavity organs, small pelvis and kidneys, peripheral lymph nodes, thyroid gland once a year, and also, respectively, the patients floor, ultrasound examination of the breast 2 times a year, mammogram from the age of forty 1 every 2 years, transrectal ultrasound examination of the prostate 2 times a year, a study of the general and free prostate-specific antigen 2 times a year. If there is no cancer detection within 10 years of the dispensary observation, the patient is considered healthy and taken off the register. When cancer is detected, the patient is clinicized for another 10 years with the above-mentioned examinations for 5 years and in the absence of a recurrence of cancer, the patient is recognized as healthy and taken off the register.EFFECT: method provides timely diagnosis of malignant neoplasms of other localization in patients after primary detection of skin cancer due to adequate timing parameters of the clinical examination with the necessary volume of examinations with clear deadlines.1 cl, 17 exИзобретение относится к медицине, а именно к онкологии, и может быть использовано для ведения пациентов после первичного выявления у них рака кожи. Для этого осуществляют диспансеризацию с проведением обследований в объёме, необходимом для своевременной диагностики новых з
